00
Days
00
Hours
00
Minutes
00
Seconds

47th Annual Meeting

Annual Meeting Theme:
Advancing Public Health: Clinical Trials in an Era of Cutting-Edge Information Capabilities

When

May 17-20, 2026

Where

Phoenix, Arizona, USA

Registration

Now Open

The Conference Venue

Arizona Grand Resort & Spa

Nestled at the base of America's largest urban park and wilderness preserve, Arizona's only four-star, all-suite resort features spacious one and two-bedroom suites. Whether meeting with colleagues or vacationing with friends, gracious service, creative culinary delights and unique recreational activities await.

Meeting | Overview

About the Annual Meeting
The Annual Meeting of the Society for Clinical Trials is a multidisciplinary program with broad participation. The Meeting brings together the clinical trials community from academia, the pharmaceutical and device industries, government agencies, medical groups and centers and clinical research entities.

Highlights include:

  • Cutting edge pre-conference workshops by leaders in the field
  • Invited sessions, targeted sessions, contributed sessions, and poster presentations
  • Founders and Curtis Meinert Keynote Lectures
  • Annual Thomas C. Chalmers Student Scholarship competition
  • Presentation by the Sylvan Green Award winner
  • Exhibitors showcasing publications, technology innovators and other resources for clinical trials
  • Discussions of timely issues and research experiences among colleagues in the field
  • Presentation of the SCT Class of 2026 Fellows
  • Presentation of the 2025 David Sackett Trial of the Year Award
  • Roundtable small group discussions on a wide range of topics
  • Networking with your colleagues

This year’s meeting will be Phoenix, Arizona, USA.

The program is being developed by the SCT Program, Education, and Student Scholarship Committees, and promises to make the best of this unique opportunity for global collaboration.

We look forward to welcoming you!

About the Society
The Society for Clinical Trials (SCT) is an educational, charitable, and scientific organization whose mission is to work internationally to advance human health through advocating the use of clinical trials, leading the development and dissemination of optimal methods and practices in clinical trials, and educating and developing all clinical trial professionals. We are a society with representation from academia, industry, government and non-profit research and advocacy groups. Our community consists of clinical investigators, biostatisticians, project managers, IT specialists, clinical research associates and people from other clinical trials specialties. Our membership spans the globe with representation from 34 different countries.

Find out more: http://www.sctweb.org/

First-Time Attendees

What to Expect During Your First SCT Meeting?

  • A community of experts across clinical trial disciplines that fosters rich cross-functional learning and collaboration.
  • A smaller, more intimate meeting that makes it easy to connect with colleagues during receptions, sessions, and networking events.
  • A diverse program of workshops, posters, and invited and contributed sessions organized into thematic tracks.
  • Engagement opportunities, including a raffle for first-time attendees.
  • A dedicated first-time attendee roundtable to help you navigate the meeting and find your place in the SCT community.

Program

Registration | Pricing

 REGISTER BY CREDIT CARD  REGISTER BY CHECK
* Please note that all registration pricing is US dollars.
Category Member Student Member Non-Member Student Non-Member
Meeting Registration
   (Early-Bird By March 23)
   (March 24 - April 27)
   (After April 27)
$725.00
$825.00
$925.00
$250.00
$275.00
$300.00
$995.00
$1095.00
$1195.00
$350.00
$375.00
$400.00
Pre-Conference Workshops Half-day
   (Sunday)
Must be registered for the SCT Annual Meeting and
pay the appropriate Meeting Registration fee.

Pre-Conference Workshop 4: Essentials of Clinical
Trials - only available to first-time attendees,
students, and post-graduates. Complimentary.
$200.00
$150.00
$250.00
$150.00
Roundtables (Monday 11:30-1:00)
Must be registered for the SCT Annual Meeting
and pay the appropriate Meeting Registration fee. 		$0.00 $0.00 $0.00 $0.00
Guest Registration Fee
(FOR NETWORKING WELCOME RECEPTION
MONDAY, MAY 18, 4:45 PM - 6:15 PM) 		$100.00 $100.00 $100.00 $100.00
  • Pre-Conference Workshops
    Participants must be registered for the SCT Annual Meeting and pay the appropriate General Registration Fee to be eligible to register for Pre-Conference Workshops. Pre-Conference Workshop 4: Essentials of Clinical Trials is only available to first-time attendees, students, and post-graduates. Those interested in registering for this complimentary workshop please email registration@sctweb.org.
  • Roundtables
    Plan to participate in one of the small group (moderator-led) discussion sessions over the Monday lunch hour. There's more than 20 topics to choose from (may attend only one). There is no fee to attend, and space is limited. Participants must be registered for the SCT Annual Meeting and pay the appropriate General Registration Fee to be eligible to register for Roundtable Discussions.
  • Discounted Fees
    Discounted fee available for attendees from developing countries. Important Note: Discounted fees are only applicable to those who currently reside in one of the listed developing countries. Discounted fees are not based on country of origin. Please email registration@sctweb.org for more information about discounts or any other questions.
  • Registration Policy
    All payments must be made in USD ($) to ensure that the full amount is received. Entry to the conference will not be permitted unless full payment has been received.
  • Cancellation Policy
    Written cancellations received via email to registration@sctweb.org by May 11th will be refunded less a $75 administrative fee. There will be no refunds issued after May 11th. Failure to attend without notice will not result in a refund.
  • Video & Photography
    By attending the meeting, attendees consent to being filmed and/or photographed for SCT purposes.

Conference | Venue

Hotel Accommodations

The SCT Annual Meeting will take place at the Arizona Grand Resort & Spa.

Arizona Grand Resort & Spa
8000 S. Arizona Grand Parkway
Phoenix, AZ 85044

Hotel Room Rate: $324 / night + 13.07% tax

Register Online:
For best availability, make your reservation at Society for Clinical Trials Annual Meeting

Register by Phone: 1-877-800-4888 (ask for the Society for Clinical Trials Annual Meeting)

**If you require a government rate, please call the hotel directly at 1-877-800-4888 and ask for the Society for Clinical Trials Annual Meeting and request the government rate with an agent.

The deadline for hotel reservations is Tuesday, April 14, 2026

Hotel reservations / rate availability are not guaranteed after the room block is full or after Tuesday, April 14, 2026. Please register early, only a limited number of rooms are available.

Location | Phoenix

Time Zone

Phoenix is in the Mountain Standard Time Zone (MST) and does not observe Daylight Saving Time.

Airport

Phoenix Sky Harbor International Airport (PHX)

Area Attractions

Phoenix offers a variety of outdoor, cultural, and entertainment attractions within a short drive of the conference hotel.

Attraction Miles from Hotel Est. Travel Time (min)
Camelback Mountain 13 25
Cosanti (Architecture Studio) 22 30
Desert Botanical Garden 8 17
Heard Museum 12 20
Hole in the Rock 8 17
Japanese Friendship Garden 13 20
Mill Avenue (Entertainment District Near ASU) 8 15
Musical Instrument Museum 27 30
OdySea Aquarium 18 21
Old Town Scottsdale 12 22
Phoenix Art Museum 12 19
Phoenix Zoo 7 13

Attractions sourced from: Phoenix New Times  |  Additional visitor information: Visit Phoenix

Program | At a Glance

We are delighted to release the provisional program for the 47th annual meeting of the Society which will run May 17-20, 2026. The theme for the 47th Annual Meeting is "Advancing Public Health: Clinical Trials in an Era of Cutting-Edge Information Capabilities". The Program includes exciting keynote lectures, cutting edge workshops, invited sessions, contributed sessions, and poster presentations on diverse topics. Contributors come from a wide range of backgrounds and disciplines representing the range of stakeholders in clinical trial research and conduct. Clicking on the icons will download session details where available. Please note that the program is not fully confirmed and speakers and timing particularly within individual sessions may be subject to some change. Note all times are Pacific.

Roundtable Topics Moderators & Descriptions
Sunday, May 17, 2026
7:00 AM - 5:00 PM
  • REGISTRATION
8:00 AM - 12:00 PM
9:45 AM - 10:15 AM
  • BREAK
12:00 PM - 1:00 PM
  • LUNCH (ON YOUR OWN)
1:00 PM - 5:00 PM
2:45 PM - 3:15 PM
  • BREAK
5:15 PM - 6:15 PM
  • SPECIAL EVENT
    Early Career & First-Time Attendee Gathering (Pre-registration required. No cost.)
7:00 PM - 8:30 PM
  • FELLOWS RECEPTION
    (By Invitation Only. Ticket Required.)
Monday, May 18, 2026
7:00 AM - 5:00 PM
  • REGISTRATION
8:00 AM - 8:15 AM
  • SCT PRESIDENT WELCOME
    Valerie Durkalski-Mauldin
8:15 AM - 8:30 AM
  • PRESENTATION OF FELLOWS CLASS
8:30 AM - 9:30 AM
  • CURTIS MEINERT KEYNOTE LECTURE
    Cyrus Hoseyni, PhD
9:30 AM - 10:15 AM
10:15 AM - 11:15 AM
  • CONTRIBUTED SESSION 1
    Trial Operations
       Dual Coordination Center Strategies for Centralized and Efficient Vendor Contracting in the ALL ALS Consortium
       From Prediction to Performance: Comparing Site Feasibility Enrollment Estimates to Actual Enrollment in Multicenter Clinical Trials
       Feasibility of Remote Research Staff for Clinical Trials
       What Trialists Should Consider When Adapting Complex Interventions for Remote Delivery: Lessons from the COVID-19 Period
  • CONTRIBUTED SESSION 2
    Trial Operations
       Advancing Multiregional Investigator-Initiated Trials: Capability Assessment and Collaborative Development through the ATLAS Network
       Public Perspectives on the Ethics and Acceptability of Decision Architecture Randomized Trials (DART)
       The Ethics of Shifting Norms in Medical and Scientific Communications
       Formation of the NeuroNEXT Patient Advisory Council: Challenges and Lessons Learned
  • CONTRIBUTED SESSION 3
    Survival Analysis and Non-Proportional Hazards
       A holistic approach for pre-powering subgroup analyses in time-to-event trials; from interaction testing to claiming efficacy
       Using the ‘average hazard ratio’ when designing survival trials under non-proportional hazards
       Kaplan-Meier Estimator and Log-rank Test in Noninferiority Trials
       Sample size determination for win statistics in cluster-randomized trials
  • CONTRIBUTED SESSION 4
    Cluster-Randomized Trial
       Designing Cluster Randomized Trials: A Practical Guide for Investigators
       Optimal sample size calculation in cost-effectiveness longitudinal cluster randomized trials
       A Shiny App for Sample Size Re-Estimation of Parallel-Arm Cluster-Randomized Trials
       AMPT: An open-source R Shiny platform to Amplify Mental Health Precision Trials
11:30 AM - 10:00 PM
  • ROUNDTABLE 1
    AI, Clinical Trials, and Biostatistics
  • ROUNDTABLE 2
    Bridging the Gap: Trial Innovation vs. Regulatory Reality
  • ROUNDTABLE 3
    Data Management Strategies for Unifying High-Velocity, Multi-Source Clinical Data
  • ROUNDTABLE 4
    Enhancing Cross-Functional Interactions: The Three Cs for Data Managers
  • ROUNDTABLE 5
    Federated learning methodologies in modern international randomized clinical trials.
  • ROUNDTABLE 6
    From Hallway Hellos to Lasting Collaborations: Networking That Works at Clinical Trials Conferences
  • ROUNDTABLE 7
    How to implement Response Adaptive Randomization
  • ROUNDTABLE 8
    Maintaining the Blind in Statistical Teams
  • ROUNDTABLE 9
    Nonadherence in clinical trials
  • ROUNDTABLE 10
    Optimizing Clinical Operations for Complex Innovative Trial Designs: Strategies and Lessons Learned
  • ROUNDTABLE 11
    Project Optimus and e-Clinical Operational Agility Strategies
  • ROUNDTABLE 12
    Streamlining DMC Data Summaries for Modern Trial Designs
  • ROUNDTABLE 13
    Strengthening Global Capacity for Investigator-Initiated Trials
    (IITs): Opportunities for International Collaboration and Industry Engagement
  • ROUNDTABLE 14
    The Crucial Role of Regulatory Specialists in Clinical Research: Safeguarding Compliance and Advancing Innovation
  • ROUNDTABLE 15
    The Role of Trial Operations at a Data Coordinating Center
  • ROUNDTABLE 16
    Using Artificial Intelligence with public partners in clinical trial research – Can AI be a collaborative tool?
  • ROUNDTABLE 17
    Beyond the Statistician: Diversifying SCT Membership
  • ROUNDTABLE 18
    Career Opportunities in Academic Data Coordinating Centers
  • ROUNDTABLE 19
    Designing Informed Consent Processes for Trials with Usual Care Groups: What practical guidance is needed?
  • ROUNDTABLE 20
    How to Make the Most of the SCT Meeting for First-Time Attendees
  • ROUNDTABLE 21
    SCT Committees and Pathways to Leadership: How to Get Involved
  • ROUNDTABLE 22
    Early-career challenges for a first role as a collaborative trial statistician
  • ROUNDTABLE 23
    Enhancing Efficiency and Quality of NIH Clinical Trial Data and Safety Monitoring: Perspectives from the Research Community
1:15 PM - 2:45 PM
  • INVITED SESSION 1
       Recent Advances in Statistical Methods for Hierarchical Composite Endpoints
  • INVITED SESSION 2
       Shaping the Next Generation of Clinical Trialists:
      Perspectives on Opportunities, Challenges, and Innovations in Training the Clinical Trials Workforce
  • INVITED SESSION 3
       Research Done Differently®: Cutting-Edge Tools for Patient-Centered Trials
  • INVITED SESSION 4
       Challenges in the Communication of Results from Randomized Clinical Trials
  • TARGETED SESSION 1
       TBD
2:45 PM - 3:30 PM
3:30 PM - 4:30 PM
  • CONTRIBUTED SESSION 5
    Adaptive Designs
       Bayesian Response-Adaptive Randomization for Cluster Randomized Controlled Trials
       CADET: Covariate-aware Adaptive Design for Efficient Trials
       Adaptive Seamless Phase 2/3 Designs with Contribution of Components Demonstration
       Early Phase Adaptive Platform Trials: Current Practice, Challenges and Opportunities
  • CONTRIBUTED SESSION 6
    Improving Clinical Trial Conduct and Monitoring
       Enhanced Regional Study Coordinator Model for Centralized Long-Term Follow-Up:
      The Colonoscopy vs. Fecal Immunochemical Test in Reducing Mortality from Colorectal Cancer (CONFIRM)
       NINDS Promotes its Innovative Approach for Funding Clinical Trials in Adult and Pediatric Populations using Other Transactions Authority
       Changing behaviours to change trials: leveraging cutting edge capabilities from behavioural science to improve trial conduct.
       PROFILE trial - disease modification with early treatment in newly-diagnosed Crohn's disease
  • CONTRIBUTED SESSION 7
    Consent and Trial Conduct
       Development of SPIRIT and CONSORT extensions for reporting climate and environmental outcomes in randomised trials (SPIRIT-ICE and CONSORT-ICE)
       International Regulatory Comparison of Emergency Consent Models and Emerging Directions in Japan: Public Acceptance and Policy Implications
       Rethinking Informed Consent: A “Staged-and-Tailored” Approach for Pragmatic Trials
       Streamlining Multicenter Trauma Research: Insights from the LITES Network and University of Pittsburgh IRB
  • CONTRIBUTED SESSION 8
    Subgroup and Heterogeneous Populations
       Pre-Planned Subgroup Analyses: Great on Paper, Tricky in Practice
       Methods for formally testing in a prespecified subpopulation in a confirmatory trial
       Bayesian Meta-analysis of Comparative Drug Safety
       SMART-Vent:
      A Bayesian Adaptive Platform Trial for Evaluating Mechanical Ventilation Strategies Using Patient-Centered Endpoints in Heterogeneous ICU Populations
  • CONTRIBUTED SESSION 9
    Complex Endpoint and Survival Analysis
       Covariate-adjusted win statistics in randomized clinical trials with ordinal outcomes
       From Biomarkers to Benefit: A Mediation-Based Framework for Surrogate Endpoints in Cardiovascular Outcome Trials
       When to Enrich? Enrollment Strategy Trade-Offs in Time-to-Event Studies With Heterogeneous Treatment Effects
       Analyzing Cardiovascular Outcomes Using Multi-State Models Beyond Time-to-First Analysis
4:45 PM - 6:15 PM
  • NETWORKING WELCOME RECEPTION
    Networking Welcome Reception
Tuesday, May 19, 2026
7:30 AM - 5:00 PM
  • REGISTRATION
8:00 AM - 9:00 AM
  • FOUNDERS KEYNOTE LECTURE
    Brandy Fureman, PhD, FAES
9:00 AM - 9:45 AM
10:00 AM - 11:30 AM
  • INVITED SESSION 5
      Regaining Trust in Clinical Trials – Fellows' Session
  • INVITED SESSION 6
      The Principal Stratum Strategy in Action: Addressing Intercurrent Events in Modern Clinical Trials
  • INVITED SESSION 7
      Extending the Reach and Impact of Randomized Clinical Trials (RCTs) through Causal Inference
  • TARGETED SESSION 2
      Data Monitoring Committees - Advancing Best Practices and Developing Next Generation Experts
11:30 AM - 12:00 PM
  • LUNCH
12:00 PM - 12:45 PM
  • SCT BUSINESS MEETING
1:00 PM - 2:00 PM
  • CONTRIBUTED SESSION 10
    Outcome Assessment and Discrete Choice Models
      Evolving Outcome Measures in Rehabilitation Trials: From Legacy Scales to Modern Metrics
      Remote Versus In-Person Cognitive Outcome Assessments in a Randomized Trial of Community-Dwelling Older Women
      REDCap Innovations to Empower Discrete Choice Experiments
      Designing trials to facilitate recruitment: insights from a discrete choice experiment
  • CONTRIBUTED SESSION 11
    Trial Operations and Monitoring
      Creating Report Dashboards Using Dynamic and Flexible SQL Generation for U.S. POINTER
      Cutting the Clutter: Streamlining Data Reports to Maximize Accountability and Boost Operational Efficiency.
      Enhancing Data Cleaning and Monitoring through Interactive Dashboards:
      Implementation of a Power BI Framework for Quality Monitoring in a Multi-Center Clinical Study
      Patterns and Timing of Protocol Deviations in a Time-Sensitive Stroke Trial
  • CONTRIBUTED SESSION 12
    Randomization and Baseline Balance
      Randomization at Crossroads: Advancing Methods, Modernizing Systems, and Updating Guidance
      Integrating Minimal Sufficient Balance Randomization into an Automated REDCap Workflow:
      Practical Considerations and Lessons Learned from an Active Clinical Trial
      Minimal Sufficient Balance Randomization for Multi-Arm Randomized Clinical Trial Designs
      Mitigating Baseline Imbalance in the MAGiNE Trial for GNE Myopathy
  • CONTRIBUTED SESSION 13
    Challenges in Modern Clinical Trials
      Estimands in Practice: Attitudes and Barriers to Implementation in UK Academic Clinical Trials Units
      Disentangling Clinical Rescue From True Treatment Effect: SEM and Propensity-Score Approaches for Intercurrent Events Under ICH E9(R1)
      Assessing Baseline Variable Imbalance in Cancer Randomized Controlled Trials: A Methodological Systematic Review
      Improving the Reporting and Feasibility Assessment of Clinical Trials with Online Components:
      Findings from a Scoping Review of Terminology and Methodological Challenges
  • CONTRIBUTED SESSION 14
    Composite Endpoint and Survival Analysis
      While-alive regression analysis of composite survival endpoints
      How does the heterogeneity in component characteristics affect statistical power in trials using composite binary endpoints?
      Methodology and Practical Considerations for Point Estimation of Novel Composite Time-To-Event Endpoints
      Optimize the use of progression-free survival (PFS) data from six published sources in the design of a small Bayesian hybrid-controlled trial that evaluates if a new therapy to treat liver-predominant metastasis from primary ocular melanoma prolongs PFS
2:00 PM - 2:30 PM
  • BREAK
2:45 PM - 3:45 PM
  • TRIAL OF THE YEAR
    Trial of the Year Session
3:45 PM - 4:00 PM
  • BREAK
4:00 PM - 5:30 PM
  • INVITED SESSION 8
      Designing and delivering robust system-level evaluations (using the evaluation of robot-assisted surgery as a motivating example)
  • INVITED SESSION 9
      Behind Multisite Trials Coordinating Center: Building and Sustaining Effective Data Coordinating Centers (DCCs)
  • INVITED SESSION 10
      Lessons Learned: Preventing and Correcting Common Challenges in Clinical Trials
  • INVITED SESSION 11
      The NN111 ExTINGUISH Trial:
      Lessons Learned in Trial Implementation, Recruitment, and Retention for a Rare Disease in an Acute Care Setting, International Clinical Trial
  • INVITED SESSION 12
      Innovative Methods for Composite Endpoints: Statistical and Clinical Perspectives
5:30 PM - 6:30 PM
  • SPECIAL EVENT
    UNICORN Special Interest Group Gathering (Pre-registration required. No cost.)
Wednesday, May 20, 2026
7:30 AM - 11:15 AM
  • REGISTRATION
8:00 AM - 9:00 AM
  • CONTRIBUTED SESSION 15
    Consent and Trial Conduct
      FASTEST Trial: A Collaborative Approach to Automated Drug Distribution Tracking in a Global Emergency Trial Setting
      Introducing the Informed Consent Design Decisions (ICDD) Framework
      Operationalizing the PREVENTABLE Study Extension: Automating Consent and Participant Decision Workflows
      Operational Challenges in a Large-Scale Pragmatic Clinical Trial in Routine Care:
      Lessons from a Centralized Clinical Research Nurse Team in the Diuretic Comparison Project
  • CONTRIBUTED SESSION 16
    Monitoring and Event Adjudication
      A Research Nurse-Led Model for Next generation Safety Event Monitoring in Clinical Trials
      REMOTE CENTRALIZED ADVERSE EVENTS ADJUDICATION IN MULTICENTER TRIALS.
      Centralized Safety Monitoring and Endpoint Review: Streamlining Multicenter Trial Oversight
      Leveraging Patient Advocacy Groups to Optimize the Clinical Trial Experience
  • CONTRIBUTED SESSION 17
    Trial Adaptation and Implementation
      Master Protocols in 2025: Myths, Realities, and Practical Guidance for Implementation
      Mid-study Implementation of a Virtual Hub-and-Spoke RCT in the VA
      Implementation of a Standardized Staffing Ratio Model and Its Associated Impact on Clinical Research Site and Network Performance in the VA Health Care System:
      A 3-Year Assessment
      Project Optimus vs Master Protocols: A Comparison of Randomization Adaptations and IRT Implementation
  • CONTRIBUTED SESSION 18
    Innovative Study Designs
      Targeting What Matters in Pediatric Trials: Bayesian Basket and Umbrella Trials for Heterogeneous Airway Disease
      Continuous monitoring of delayed outcomes in basket trials
      Zero Inflated Outcomes in SMART Designs
      Using Clinical Trial Data in Combination with Pharmacokinetics to Inform Novel Study Designs
  • CONTRIBUTED SESSION 19
    Methods for Complex Interventions
      Addressing Cluster-Level Treatment Effect Heterogeneity in Sample Size Determination for Hierarchical 2x2 Factorial Designs
      Identification and Estimation of Causal Effects of Components of a Bundled Intervention
      Study Designs and Methods for Intervention Delivery, Data Analysis, and Sample Size Proposed in NIH-Supported Phase 2 and 3 Clinical Trials
      Efficiency and bias in estimating treatment effects for stepped wedge designs with time effects and without time effects
9:00 AM - 9:15 AM
  • BREAK
9:15 AM - 10:45 AM
  • INVITED SESSION 13
      Beyond Blocks: A New Era of Randomization
  • INVITED SESSION 14
      Avoid Data Indigestion: Ingestion and Management of Complex and Novel Data at Academic Data Centers
  • INVITED SESSION 15
      Statistical and Practical Issues in Implementation Trials
  • INVITED SESSION 16
      Design and Operational Considerations for Long COVID Clinical Trials
  • TARGETED SESSION 3
      Bridging Innovation and Impact: Uniting the Statistical Innovation Community with the Society for Clinical Trials
10:45 AM - 11:00 AM
  • BREAK
11:00 AM - 12:30 PM
  • INVITED SESSION 17
      From Data to Decisions: Why investing in MedDRA coding and quality reviews pays off
  • INVITED SESSION 18
      Non-inferiority trials yield results that are arbitrary, obscure, and unreliable. What are the alternatives?
  • INVITED SESSION 19
      Innovating Trial Design and Analysis for Discovery Medicine:
      Clinical, Statistical and Regulatory Perspectives and Lessons from Early-Phase Trials of Broadly Neutralizing Antibody-Inducing HIV Vaccines
  • INVITED SESSION 20
      Rethinking the Stepped-Wedge Design amid Time-Varying Treatment Effects: Implications, Modeling Strategies, and Practical Evidence
  • INVITED SESSION 21
      From Integration to Dissemination: Data and Statistical Management in a Perpetual ALS Platform Trial

Frequently | Asked

Have a question? If you do not find the answer in our most frequently asked questions
below, please reach out to us at contact@sctweb.org.

The early registration deadline is Monday, March 23, 2025 (Midnight Central Standard Time).
Please click here to view the list of qualifying countries.
Discounted fees are only applicable to those who currently reside in one of the listed developing countries.
We request that all online registrations are paid for by credit card through the secure registration system.
All payments must be made in USD ($) to ensure that the full amount is received.
Credit cards are charged in real time at the time the registration is processed.
Yes. We accept Visa, MasterCard and American Express.

If you need an invitation letter to the conference for your VISA application, you will need to register for the meeting by the early bird registration deadline (March 23rd).

To request an Invitation Letter for the SCT Annual Meeting, please send a request to KellyBurns@sctweb.org after you have completed your registration and received a Meeting Confirmation/Receipt. The letter is subject to approval by office staff and will be sent to you by email.

You must be registered for the Annual Meeting to receive a letter.

If you have not received a receipt, please email registration@sctweb.org or call (847) 427-8010.
No. All registrations are non-transferable. Any new attendee would need to register for the meeting on their own at the current registration rate..
Guest Registration is for the Networking Welcome Reception only. They are denied access to any and all educational sessions.
One-day or partial registrations are not available. Registration is for the entire meeting at the given rates.
All who are invited to participate in the program as Session Organizers, Session Chairs, Moderators, Presenters/Speakers, Discussants, Panelists, Oral/Poster Presenters, etc. are required to register for the meeting and pay all applicable fees, attend the meeting in-person to present, and make their own travel and housing arrangements paying all expenses on their own.
Yes. Participants must be registered for the SCT Annual Meeting and pay the appropriate General Registration Fee to be eligible to register for Pre-Conference Workshops.
Yes. Participants must be registered for the SCT Annual Meeting and pay the appropriate General Registration Fee to be eligible to register for Roundtable Discussions.
The government rate is only applicable to those employed by the United States government.
To make changes to your housing reservation, you must contact the hotel directly.
Society for Clinical Trials